Skip to main content

Published locations for GlaxoSmithKline Pulls Lapatinib Submission Ahead of ODAC Review

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. GlaxoSmithKline Pulls Lapatinib Submission Ahead of ODAC Review

User login

  • Reset your password
  • /content/glaxosmithkline-pulls-lapatinib-submission-ahead-odac-review
  • /obgynnews/article/55278/breast-cancer/glaxosmithkline-pulls-lapatinib-submission-ahead-odac-review
  • /oncologypractice/article/55278/breast-cancer/glaxosmithkline-pulls-lapatinib-submission-ahead-odac
  • /obgyn/article/55278/breast-cancer/glaxosmithkline-pulls-lapatinib-submission-ahead-odac-review
  • /hematology-oncology/article/55278/breast-cancer/glaxosmithkline-pulls-lapatinib-submission-ahead
  • /breast-cancer-icymi/article/55278/breast-cancer/glaxosmithkline-pulls-lapatinib-submission-ahead